Literature DB >> 30456630

[ESC/EACTS guidelines on myocardial revascularization 2018 : The most important innovations].

F-J Neumann1, W Hochholzer2, M Siepe3.   

Abstract

The guidelines on myocardial revascularization published in 2018 are a joint initiative of the European Society of Cardiology and the European Association for Cardio-Thoracic Surgery. To establish indications for myocardial revascularization by percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG), evidence of the functional relevance of coronary artery stenoses is needed either by non-invasive imaging function tests or intravascular hemodynamic measurements. The prognostic and symptomatic benefits of myocardial revascularization depend on whether complete revascularization can be achieved. This needs to be considered when choosing the most appropriate revascularization strategy. In addition, the individual operative risk, the technical feasibility, the presence of diabetes mellitus and the anatomical complexity of coronary artery disease, as assessed by the SYNTAX score, are key criteria when choosing the optimal method of revascularization. For PCI radial artery access and the general use of drug-eluting stents are recommended. For CABG multiple arterial grafts should be strived for including the radial artery for treatment of high-grade coronary stenosis.

Entities:  

Keywords:  Coronary artery bypass grafting; Drug-eluting stents; Myocardial ischemia; Percutaneous coronary intervention; Radial artery

Mesh:

Year:  2018        PMID: 30456630     DOI: 10.1007/s00059-018-4764-5

Source DB:  PubMed          Journal:  Herz        ISSN: 0340-9937            Impact factor:   1.443


  9 in total

1.  Outcomes after complete versus incomplete revascularization of patients with multivessel coronary artery disease: a meta-analysis of 89,883 patients enrolled in randomized clinical trials and observational studies.

Authors:  Santiago Garcia; Yader Sandoval; Henri Roukoz; Selcuk Adabag; Mariana Canoniero; Demetris Yannopoulos; Emmanouil S Brilakis
Journal:  J Am Coll Cardiol       Date:  2013-06-07       Impact factor: 24.094

2.  PCI Strategies in Patients with Acute Myocardial Infarction and Cardiogenic Shock.

Authors:  Holger Thiele; Ibrahim Akin; Marcus Sandri; Georg Fuernau; Suzanne de Waha; Roza Meyer-Saraei; Peter Nordbeck; Tobias Geisler; Ulf Landmesser; Carsten Skurk; Andreas Fach; Harald Lapp; Jan J Piek; Marko Noc; Tomaž Goslar; Stephan B Felix; Lars S Maier; Janina Stepinska; Keith Oldroyd; Pranas Serpytis; Gilles Montalescot; Olivier Barthelemy; Kurt Huber; Stephan Windecker; Stefano Savonitto; Patrizia Torremante; Christiaan Vrints; Steffen Schneider; Steffen Desch; Uwe Zeymer
Journal:  N Engl J Med       Date:  2017-10-30       Impact factor: 91.245

3.  Interpretation of results of pooled analysis of individual patient data - Authors' reply.

Authors:  Stuart J Head; Grigorios Papageorgiou; Milan Milojevic; Gregg W Stone; A Pieter Kappetein
Journal:  Lancet       Date:  2018-09-08       Impact factor: 79.321

4.  Considerations for the choice between coronary artery bypass grafting and percutaneous coronary intervention as revascularization strategies in major categories of patients with stable multivessel coronary artery disease: an accompanying article of the task force of the 2018 ESC/EACTS guidelines on myocardial revascularization.

Authors:  Stephan Windecker; Franz-Josef Neumann; Peter Jüni; Miguel Sousa-Uva; Volkmar Falk
Journal:  Eur Heart J       Date:  2019-01-07       Impact factor: 29.983

5.  2018 ESC/EACTS Guidelines on myocardial revascularization.

Authors:  Franz-Josef Neumann; Miguel Sousa-Uva; Anders Ahlsson; Fernando Alfonso; Adrian P Banning; Umberto Benedetto; Robert A Byrne; Jean-Philippe Collet; Volkmar Falk; Stuart J Head; Peter Jüni; Adnan Kastrati; Akos Koller; Steen D Kristensen; Josef Niebauer; Dimitrios J Richter; Petar M Seferovic; Dirk Sibbing; Giulio G Stefanini; Stephan Windecker; Rashmi Yadav; Michael O Zembala
Journal:  Eur Heart J       Date:  2019-01-07       Impact factor: 29.983

6.  Guided de-escalation of antiplatelet treatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention (TROPICAL-ACS): a randomised, open-label, multicentre trial.

Authors:  Dirk Sibbing; Dániel Aradi; Claudius Jacobshagen; Lisa Gross; Dietmar Trenk; Tobias Geisler; Martin Orban; Martin Hadamitzky; Béla Merkely; Róbert Gábor Kiss; András Komócsi; Csaba A Dézsi; Lesca Holdt; Stephan B Felix; Radoslaw Parma; Mariusz Klopotowski; Robert H G Schwinger; Johannes Rieber; Kurt Huber; Franz-Josef Neumann; Lukasz Koltowski; Julinda Mehilli; Zenon Huczek; Steffen Massberg
Journal:  Lancet       Date:  2017-08-28       Impact factor: 79.321

7.  2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS).

Authors:  Marco Valgimigli; Héctor Bueno; Robert A Byrne; Jean-Philippe Collet; Francesco Costa; Anders Jeppsson; Peter Jüni; Adnan Kastrati; Philippe Kolh; Laura Mauri; Gilles Montalescot; Franz-Josef Neumann; Mate Petricevic; Marco Roffi; Philippe Gabriel Steg; Stephan Windecker; Jose Luis Zamorano; Glenn N Levine
Journal:  Eur Heart J       Date:  2018-01-14       Impact factor: 29.983

8.  Coronary-Artery Bypass Surgery in Patients with Ischemic Cardiomyopathy.

Authors:  Eric J Velazquez; Kerry L Lee; Robert H Jones; Hussein R Al-Khalidi; James A Hill; Julio A Panza; Robert E Michler; Robert O Bonow; Torsten Doenst; Mark C Petrie; Jae K Oh; Lilin She; Vanessa L Moore; Patrice Desvigne-Nickens; George Sopko; Jean L Rouleau
Journal:  N Engl J Med       Date:  2016-04-03       Impact factor: 91.245

Review 9.  Mortality after coronary artery bypass grafting versus percutaneous coronary intervention with stenting for coronary artery disease: a pooled analysis of individual patient data.

Authors:  Stuart J Head; Milan Milojevic; Joost Daemen; Jung-Min Ahn; Eric Boersma; Evald H Christiansen; Michael J Domanski; Michael E Farkouh; Marcus Flather; Valentin Fuster; Mark A Hlatky; Niels R Holm; Whady A Hueb; Masoor Kamalesh; Young-Hak Kim; Timo Mäkikallio; Friedrich W Mohr; Grigorios Papageorgiou; Seung-Jung Park; Alfredo E Rodriguez; Joseph F Sabik; Rodney H Stables; Gregg W Stone; Patrick W Serruys; Arie Pieter Kappetein
Journal:  Lancet       Date:  2018-02-23       Impact factor: 79.321

  9 in total
  3 in total

1.  Comparison of ticagrelor and clopidogrel in the treatment of patients with coronary heart disease carrying CYP2C19 loss of function allele.

Authors:  Wenwen Qian; Liang Chen; Lizhu Zhang; Mingzhu Gao; Chunxia Wang; Xi Qian; Chengjian Yang; Yahui Lin; Zhijun Han
Journal:  J Thorac Dis       Date:  2022-07       Impact factor: 3.005

Review 2.  A Practical Approach to Invasive Testing in Ischemia With No Obstructive Coronary Arteries (INOCA).

Authors:  Alexandra Bastiany; Christine Pacheco; Tara Sedlak; Jaqueline Saw; Steven E S Miner; Shuangbo Liu; Andrea Lavoie; Daniel H Kim; Martha Gulati; Michelle M Graham
Journal:  CJC Open       Date:  2022-05-04

Review 3.  Comprehensive overview of Nrf2-related epigenetic regulations involved in ischemia-reperfusion injury.

Authors:  Jun Zhang; Wanqian Pan; Yue Zhang; Mingyue Tan; Yunfei Yin; Yuanmei Li; Lei Zhang; Lianhua Han; Jiaxiang Bai; Tingbo Jiang; Hongxia Li
Journal:  Theranostics       Date:  2022-09-11       Impact factor: 11.600

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.